High Tide Inc.

NASDAQ:HITI

Medical - Pharmaceuticals

Healthcare
$2.37 -2.11%

-$0.05 today

Market cap
$211.27M
Beta
0.57
P/E (TTM)
-6.6
EPS (TTM)
-$0.50
52W Low $2.12High $4.06

Volume 0.32M

Average 0.61M

HITI Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

High Tide Inc.NASDAQ: HITI

Gross Profit · Q2 FY2026 · quarter ended Apr 2026

Gross profit declines year over year

Q2 FY2026 gross profit of CA$20.08M fell 43.4% year over year, behind the -17.2% change in trailing-twelve-month gross profit. Sequentially, it rose 34.5% from the prior quarter. Over 3 fiscal years it compounded at +15.0% a year.

Context

  • Gross profit amounted to 25.8% of revenue in FY2025, down 1.4 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -43.4% toward the trailing-twelve-month pace of -17.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
CA$20.08M+34.5% QoQ
Last fiscal yearOct 2025
CA$153.53M+7.7% YoY
LTMApr 2026
CA$117.63M-17.2% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-43.4%——
1 year+7.7%——
3-year CAGR+15.0%——
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2025
153.53M CAD
Year-over-year change
+7.7%
4-year CAGR
+24.5%

Gross Profit vs competitors

How HITI compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -17.2% is the 5th highest of 6, against a peer median of -7.5%.
  • Gross profit amounts to 17.5% of revenue for HITI, versus a peer median of 42.2%.
HITI Competitors
Gross Profit for HITI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$133.27M USD-10.0%+3.6%50.9%
HITIHigh Tide Inc.LTM Apr 2026CA$117.63M CAD-17.2%+15.0%17.5%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$75.4M CAD+9.0%+73.8%47.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$73.53M CAD-7.5%—23.6%
CRON.TOCronos Group Inc.LTM Mar 2026$67.28M USD+71.5%+58.2%42.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$8.41M CAD-113.3%—3.1%
Peer median (excluding HITI) —-7.5%+58.2%42.2%

Competitors are the stored peer set for HITI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue181.12M356.85M487.67M522.31M593.99M
Cost of Revenue117.14M255.9M356.36M379.8M440.46M
Gross Profit63.98M100.95M131.31M142.5M153.53M
Gross Margin35.3%28.3%26.9%27.3%25.8%
Research & Development00000
Selling, General & Admin54.27M90.9M101.21M101.79M113.78M
Operating Expenses82.66M173.26M172.74M137.5M167.98M
Depreciation & Amortization23.57M30.17M32.76M25.39M24.31M
EBITDA(1.96M)(33.65M)(4.2M)33.78M(13.74M)
EBITDA Margin-1.1%-9.4%-0.9%6.5%-2.3%
Operating Income(18.67M)(72.31M)(41.43M)5M(14.45M)
Operating Margin-10.3%-20.3%-8.5%1.0%-2.4%
Interest Income00000
Interest Expense10.24M9.95M11.64M12.79M13.38M
Other Income / Expenses(17.09M)(1.45M)(7.17M)(9.41M)(36.98M)
Income Before Tax(35.77M)(73.76M)(48.6M)(4.4M)(51.43M)
Pre-Tax Margin-19.7%-20.7%-10.0%-0.8%-8.7%
Income Tax Expense(730K)(2.92M)(7.64M)(593K)(25K)
Net Income(34.36M)(71.76M)(39.31M)(4.34M)(50.75M)
Net Margin-19.0%-20.1%-8.1%-0.8%-8.5%
EPS (Basic)(0.83)(1.13)(0.53)(0.05)(0.62)
EPS (Diluted)(0.83)(1.13)(0.53)(0.05)(0.62)
Weighted Avg Shares42.43M62.78M74.33M79.56M82.18M
Weighted Avg Shares (Diluted)42.43M62.78M74.33M79.56M82.18M

High Tide Inc.

NASDAQ:HITI

Intrinsic Alpha fair value

Locked

Current Price

$2.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.